News Lilly slashes insulin price 70%, patient cost cap now $35 Lilly trying to make it easier for patients to access its insulin and help Americans generally.
News Leqembi still too pricey, says ICER in updated review Side effects create 'uncertainties' as to whether lecanemab's benefits exceed its risks.
News Santhera shores up funding ahead of vamorolone verdict The FDA is due to deliver a verdict on vamorolone in Duchenne muscular dystrophy in October.
News Northern Ireland Brexit deal restores MHRA jurisdiction Regulator regains the power to approve medicines in Northern Ireland under Windsor Framework.
News Phase 3 trial win sets up rare disease drug filing for CSL VANUGUARD trial of garadacimab in HAE sets up a pursuit of Takeda's fast-growing Takhyzro.
News Forget Merck, now Pfizer is said to be after Seagen Rumour of negotiations comes as Pfizer is facing a steep patent cliff in the next few years.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
